Suppr超能文献

1098 例经导管主动脉瓣置换术患者的预后:一项全州人群关联队列研究。

Outcomes of 1,098 Patients Following Transcatheter Aortic Valve Implantation: A Statewide Population-Linkage Cohort Study.

机构信息

Department of Cardiology, Concord Hospital, The University of Sydney, Sydney, NSW, Australia.

Department of Cardiology, Concord Hospital, The University of Sydney, Sydney, NSW, Australia.

出版信息

Heart Lung Circ. 2021 Aug;30(8):1213-1220. doi: 10.1016/j.hlc.2021.02.007. Epub 2021 Mar 12.

Abstract

BACKGROUND

The increasing implementation of transcatheter aortic valve implantation (TAVI) in Australia warrants real-world data on the prevalence and outcomes of these patients. The aim of this study is to describe trends in case-volumes of TAVI in New South Wales (NSW), Australia and associated mortality outcomes.

METHODS

From the Centre of Health Record Linkage registry, all NSW residents who underwent TAVI between 5 June 2013 and 30 June 2018 were identified. Cause-specific mortality was tracked from the statewide death registry. Temporal trends in case-volumes between 2013 and 2018 were assessed by linear regression. Binary logistic regression was used to compare differences in in-hospital and 30-day mortality, while Cox proportional hazards regression was used to compare mortality beyond 30 days.

RESULTS

Case-volumes increased from 30 in 2013 to 345 by 2017. The cohort comprised 1,098 persons (mean[±SD] age: 83.3±7.7 yrs). Cumulative in-hospital, 180-day and at end-of-study (mean: 1.8±1.2 yrs) all-cause mortality were 1.3% (n=14), 4.9% (n=54) and 20.3% (n=224) respectively. Heart failure (14.3%, n=2), myocardial infarction (14.3%, n=2), and sepsis (14.3%, n=2) were the primary causes of in-hospital death. Post-discharge, sepsis (25.2%, n=53) was the main cause-specific death, while combined cardiovascular deaths accounted for 46% (n=97), mostly from heart failure (n=35). Heart failure, chronic kidney disease, and requirement for ventilation post-TAVI were independent predictors of in-hospital death and at 180 days. TAVI procedure in low-volume public centres was a predictor of mortality at 180 days.

CONCLUSION

The number of TAVI procedures increased 10-fold between 2013 and 2017 state-wide, with mortality rates comparable to international cohorts at short and medium-term follow-up. Pre-existing comorbidities and site-specific caseloads may be important determinants of outcome, emphasising the importance of appropriate patient selection and treating centre.

摘要

背景

经导管主动脉瓣植入术(TAVI)在澳大利亚的应用日益广泛,因此需要了解该手术在真实世界中的患者数量和预后情况。本研究旨在描述新南威尔士州(NSW)TAVI 病例数量的变化趋势及其相关的死亡率。

方法

从健康记录链接中心的登记处中,确定了 2013 年 6 月 5 日至 2018 年 6 月 30 日期间在新南威尔士州接受 TAVI 的所有居民。通过全州死亡登记处对特定原因的死亡率进行跟踪。通过线性回归评估 2013 年至 2018 年期间病例数量的时间趋势。使用二元逻辑回归比较住院和 30 天死亡率的差异,使用 Cox 比例风险回归比较 30 天以上的死亡率。

结果

病例数量从 2013 年的 30 例增加到 2017 年的 345 例。该队列包括 1098 人(平均[±标准差]年龄:83.3±7.7 岁)。住院期间、180 天和研究结束时(平均:1.8±1.2 年)的全因死亡率分别为 1.3%(n=14)、4.9%(n=54)和 20.3%(n=224)。心力衰竭(14.3%,n=2)、心肌梗死(14.3%,n=2)和败血症(14.3%,n=2)是住院期间死亡的主要原因。出院后,败血症(25.2%,n=53)是主要的特定原因死亡,而心血管联合死亡占 46%(n=97),主要来自心力衰竭(n=35)。心力衰竭、慢性肾脏病和 TAVI 后需要通气是住院期间死亡和 180 天的独立预测因素。低容量公共中心的 TAVI 手术是 180 天死亡率的预测因素。

结论

2013 年至 2017 年期间,TAVI 手术的数量增加了 10 倍,短期和中期随访的死亡率与国际队列相当。预先存在的合并症和特定部位的病例量可能是结果的重要决定因素,强调了适当的患者选择和治疗中心的重要性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验